Lipoproteins and Diabetic Microvascular Complications

E-ISSN： 1873-4286|10|27|3395-3418

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.27, 2004-10, pp. : 3395-3418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose Reductase in Diabetic Microvascular Complications

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of VEGF Inhibition in Diabetic Microvascular Complications

By Tremolada Gemma

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 6, 2007-01 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

The Role of Lipids in the Development of Diabetic Microvascular Complications: Implications for Therapy

By Misra A.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 325-338

Adis International

Access to resources Recommend Favorite

Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control

By Verrotti Alberto Trotta Daniela Salladini Carmela Laura Madonna Chiarelli Francesco

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 525-532

Informa Healthcare

Access to resources Recommend Favorite

The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

By Vinik Aaron

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1547-1559

Informa Healthcare

Access to resources Recommend Favorite